Stocks and Investing Stocks and Investing
Tue, May 2, 2023

Emily Bodnar Reiterated (ACRV) at Strong Buy and Held Target at $24 on, May 2nd, 2023


Published on 2024-10-28 03:15:52 - WOPRAI, Emily Bodnar
  Print publication without navigation


Emily Bodnar of HC Wainwright & Co., Reiterated "Acrivon Therapeutics, Inc." (ACRV) at Strong Buy and Held Target at $24 on, May 2nd, 2023.

Emily, nor any peers, have made any analyst calls on ACRV in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources